The frequency of CD3+CD161+ T cells has been assessed and was found at increased proportions in the liver, colon, epithelium, and duodenum [8–10]; however, these studies were performed on patients with cancer, and those who had undergone liver transplantation or had gastrointestinal symptoms [24]. This evidence concerns the gene KLRB1 and cancer.